HIV / AIDS in the News

South Africa launches bid to enable local production of long-acting HIV prevention drug, lenacapavir - Unitaid

 

South Africa seeks local production of Gilead's HIV prevention drug - Reuters

 

South Africa seeks local production of Gilead's HIV prevention drug - TradingView

 

LGBTQ Agenda: Florida makes drastic changes to AIDS drug program - Bay Area Reporter

 

Clinical Presentation and Mortality Among Hospitalized People Living With HIV at a Tertiary Care Institute in Mumbai, India - Cureus

 

Clinical Presentation and Mortality Among Hospitalized People Living With HIV at a Tertiary Care Institute in Mumbai, India - Cureus

 

New HIV single-tablet regimen ‘a more suitable long-term treatment option’ - Medical Republic

 

Denmark makes history by eliminating HIV and syphilis transmission to babies - Earth.com

 

Machine-learning immune-system analysis study may hold clues to personalized medicine - Medical Xpress

 

Multiple Eruptive Dermatofibromas in a Patient With HIV Infection: A Case Report - Cureus

 

A New One-A-Day-Pill Holds Promise For HIV’s ‘Forgotten Population’ - The Brasilians

 

Chloe Orkin BIC LEN HIV ARTISTRY Gilead once daily pill CROI - Infectious Disease Special Edition

 

Let me see you One2PrEP: Gilead campaign targets stigma with pop culture punch - Medical Marketing and Media

 

Maria Davis: Living Out Loud with HIV - poz.com

 

Time for HIV Testing & Testing Regularly - 105.3 RnB

 

More States Consider Limiting Access To HIV Treatment - Black Enterprise

 

HIV Gene Expression Detection Tool Opens Viral Treatment Directions - Genetic Engineering and Biotechnology News

 

Jacksonville HIV advocate warns of crisis as thousands lose medication access - News4JAX

 

‘It isn’t fair’: Jacksonville HIV advocate warns of crisis as thousands lose medication access, but relief may be coming - News4JAX

 

One2PrEP Takes HIV Prevention to Center Stage, Using Culture and Conversation to Break Stigma - Contagion Live

 

Western leads new international, public-private initiative for equitable access to HIV cure - Schulich School of Medicine & Dentistry

 

Leading HIV Researchers Reflect on Breakthroughs, Challenges at CROI 2026 - The American Journal of Managed Care® (AJMC®)

 

Doravirine/Islatravir Combo Pill Could Soon Be a New HIV Treatment Option - poz.com

 

Beyond Viral Suppression: Next-Generation HIV Therapeutics Target Reservoirs, Broadly Neutralizing Antibodies, and Gene Editing - Infection Control Today

 

Beyond Viral Suppression: Next-Generation HIV Therapeutics Target Reservoirs, Broadly Neutralizing Antibodies, and Gene Editing - Infection Control Today

 

NIH-Supported Trial Reduces HIV Incidence by 70% in Rural Populations - poz.com

 

Prospects for Merck & Co’s DOR/ISL in HIV - The Pharma Letter

 

Budget cuts and ignorance of history are racing us towards another HIV & AIDS epidemic - Advocate.com

 

Dolutegravir restores gut microbiota in late-stage HIV-1 unlike darunavir: an open-label, randomized clinical trial - Nature

 

Broadly Neutralizing Antibody Helps Maintains Viral Suppression - poz.com